July Journal published as Impact Factor soars to 2.1!

The July edition of the Journal is now available online and includes: Venous thromboembolism and COCs: an ongoing saga This ongoing controversy recently resulted in the decision of the French authorities to withdraw the combined oral contraceptive (COC) containing ethinylestradiol (EE) and cyproterone acetate (i.e. Diane 35®) from the market. This consensus statement from 26 […]

Read More…

New injectable – Sayana Press and Dianette VTE update

Sayana Press® is a progestogen-only injectable contraceptive licensed for subcutaneous use. It contains 104mg of medroxyprogesterone acetate (MPA) in 0.65ml suspension and is bioequivalent to IM depot medroxyprogesterone acetate. It is administered at intervals of 13 weeks +/- 7 days via a new delivery system (Unijet) – a single dose pre-filled injector. Although ideal for […]

Read More…

GUNA Summer Meeting

  GUNA Summer Clinical Meeting – Shaping Best Practice   GUNA is holding its summer meeting on 28th June at Jury’s Inn Hotel, Islington. The GUNA summer clinical meeting for 2013 is being held on Friday 28th June and focuses on ‘Shaping Best Practice.’ Bringing together some of the UK’s most renowned sexual health practitioners, […]

Read More…

Copenhagen Impressions

European Society of Contraception and Reproductive Health First Global Conference Highlights of the Congress included: Crown Princess Mary opening the Congress followed by the amazing Copenhagen drummers                                Green contraception – estrogen in water an issue, rating methods for their ‘greenness’: hormones, packaging etc. Lidegaard / Shulman / Dinger – continuing debate on […]

Read More…